December, 2017

With the Los Angeles tech scene exploding, CrossCut Ventures raises $125 million to invest

TechCrunch LA

CrossCut Ventures, a Los Angeles-based seed investment firm has just closed its fourth (and largest) fund with $125 million in new cash. It’s been a long road for the firm’s three co-founders, who have been investing in Los Angeles since 1997.

Silicon Beach Report Dec. 8: Snapchat Gets Up To $1 Million a Day for Branded Augmented Reality

L.A. Business Journal

Snapchat gets up to $1 million a day for branded augmented reality; K1 invests $200 million in SecureAuth; and Disney adds tech execs to board

Trending Sources

Gene Therapy Advances, But Hemophilia is no Easy Target


Mark Skinner, the former longtime president of the World Federation of Hemophilia, has had the blood disease on his mind his entire life. He doesn’t have a choice.

Gift Guide 2017: Star Wars Gadgets and Gear


Star Wars. The franchise is one of the most famous of all time — the original 1977 film is up there with Gone With the Wind as the most beloved 20th century flick. Unlike Gone With the Wind , the futuristic Star Wars franchise lends itself incredibly well to branded tech gadgets. And also (sadly?)

Guide 30

More Trending

High-End Drone Tech Finds Way

L.A. Business Journal

How domestic drone makers can fly above offshore competitors

Clora Reaps $3.3M to Speed Consultant Hunts by Life Sciences Companies


Rahul Chaturvedi worked for 16 years as a life sciences company executive, but he was also an avid consumer tech fan who chafed at the clunky enterprise apps used in his industry.

Why Coachella Valley Is a Hub for Renewable Energy Startups


Coachella Valley is referred to as the “Desert Empire” to differentiate it from the neighboring urbanized Inland Empire and the Imperial Valley. The Valley also houses desert resort cities of Palm Springs and Palm Desert and is the location for the infamous Coachella Music Festival.

Why We Must Have Zero Tolerance for Sexual Misconduct in Venture Capital

Both Sides of the Table

Time Magazine published its “person of the year” edition today and honored “the silence breakers” for speaking up and forcing our society to confront its position towards men in power exploiting their power for sexual gain. Real change is clearly needed.

HAAWK Buys RoyaltyClaim and TuneRegistry


Los Angeles-based a href="[link] , the startup led by Ryan Born which focuses on rights management, copyright enforcement, and content monetization, has acquired two startups, TuneRegistry , and RoyaltyClaim. Financial terms of the acquisition were not announced. As part of the acquisition, HAAWK said it has named TuneRegistry and RoyaltyClaim founder Dae Bogan as CEO, and named TuneRegistry co-founders Jesse Morris, Kara McGehee, and Shane Zilinskas will serve as HAAWK's CLO, CPO, and CTO.


Education technology meets its limits

TechCrunch LA

This week has been a good one for those who like to talk about the limits of technology. Over in the UK, a prankster managed to fool Trip Advisor into naming his shed the #1 ranked restaurant in London. Meanwhile, in Los Angeles, a city struggling to manage several wind-fueled wildfires, the L.A.P.D.

Blockchain-Based Health Care Start-Up Curisium Raises $3.5 Million

L.A. Business Journal

Curisium, a Manhattan Beach–based start-up company that allows health care systems and biotech firms to contract through blockchain technology, has raised $3.5 million from investors, officials announced Thursday


Black Venture Capitalists Are Transforming Tech


Would it surprise you to know that there are more than 100 black venture capitalists or that this nationwide ecosystem is growing? Most of the VCs in this expanding ecosystem made pivots from highly successful careers in other fields.


SoCal Tech Calendar

Thursday, December 14, 2017 -- AIMed: Artificial Intelligence In Medicine. Event on AI in medicine and healthcare. See [link] (more


How would you like a great advisory board?


Have you ever thought of creating an advisory board? As you can guess, that would be an informal group with no legal responsibilities, but one able to be called upon to act as business, industry and scientific advisors to you and the company.


Mondicon Sets Up Shop In Santa Monica, Rolls Out Mobile WiFi Hardware


Dutch electronics developer Mondicon said Wednesday afternoon that it is setting up an office in Santa Monica, as it launched its products into the United States. The company said it is launching a secure, mobile Wi-Fi hotspot it calls the We.Stream at CES, a secure, mobile hotspot that lets users purchase data in increments of 2GB, 5GB or 10GB from its own touch screen. The company said it is now looking for U.S.based distributors and resellers for its device, which costs $179. READ MORE>>.


Ginkgo Bioworks Pulls In $275M as Synthetic Biology Funding Soars


Companies sometimes raise big venture capital rounds to invest in equipment, people, and other tools for growth. Other times they do it to provide the business a cash cushion. And sometimes it’s about giving potential customers and partners more confidence in the fledgling company.


Silicon Beach Report Dec. 5: Hyperloop One Co-Executive Chairman Shervin Pishevar Takes Leave of Absence

L.A. Business Journal

Hyperloop One Co-Executive Chairman Shervin Pishevar takes leave of absence, Ziff Davis to close Mashable acquisition for $50 million and lay off 50 people and Relativity Space aims to 3-D print entire launch vehicles

Dynavax Co-founder Takes Long View on Vaccine Development


The reaction on Wall Street was a little anticlimactic after the FDA approved a new hepatitis B vaccine last month for Berkeley, CA-based Dynavax Technologies (NASDAQ: DVAX ). Many investors sold stock on the news. In the days following the company’s Nov.

News 27

Miso Robotics Hires COO to Help Expand Restaurant Installations

L.A. Business Journal

Miso Robotics, a maker of burger-flipping robotic arms, announced it has appointed former Yahoo executive Melissa Burghardt as its chief operating officer

Yahoo 30

ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More


The annual American Society of Hematology meeting is nearly over. For now, we’ve chosen updates from three disease areas to highlight, plus the more notable market movements. No surprise, there’s a lot about the genetically engineered cell therapy known as CAR-T. Gene therapy and more standard forms of care are up for discussion, too. If you’re not ASH-saturated by now, stay tuned: We’ll have more hematology coverage later this week.

15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)


Many of biotech’s biggest stories in 2017 followed the highly anticipated data from clinical studies. There were monumental successes, like the first-ever approval of a genetically modified living cell therapy , the first FDA application for a gene therapy or a medicine using RNA interference. There were also stinging failures, such as the latest in a long line of hyped Alzheimer’s disease drugs to fall flat.

Study 18

Silicon Beach Dec. 13: Online Bank Aspiration Raises $47 Million

L.A. Business Journal

Online bank Aspiration raises $47 million; Dreamscape Immersive partners with Nickelodeon for virtual reality project; and Sophia Amoruso’s digital media firm Girlboss raises another $2 million

Media 22

What Are the Nation’s Top Cities and Regions for Driverless Tech?


View the Slideshow Whether you think self-driving cars are the stuff of science fiction or a potentially paradigm-shifting new form of transportation, autonomous vehicles are coming—and the companies developing them are spending big money to make it happen. A few years ago, industry analysts seemed to think Silicon Valley would win the race to get self-driving cars on the road—and plenty of tech giants are involved in their development, including Apple, Google, Uber, Tesla, and Intel.

Silicon Beach Report Dec. 12: Miso Robotics Hires COO to Help Expand Restaurant Installations

L.A. Business Journal

Miso Robotics hires COO to help expand restaurant installations; NASA sees equivalent risk of launching used SpaceX rocket booster; and satellite data analysis startup Slingshot Aerospace raised $3.25 million

Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More


A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency of headaches. These drugs still await an FDA decision, and their impact on patients over the long term are being watched closely. As many as 38 million Americans suffer from migraines, according to the Migraine Research Foundation. Migraine sufferers and their physicians and patients are looking for new treatment options. In other pharma news this week, U.S.

News 16

Case’s $150M Rise of the Rest Fund Aims to Boost Flyover Startups


Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful entrepreneurs in the country. Called the Rise of the Rest Seed Fund , it will be overseen by Case and Hillbilly Elegy author J.D. Vance, who joined Case’s VC firm, Revolution, earlier this year.

15 For ’18: Key Clinical Data to Watch For Next Year (Part 2)


On Monday we posted the first part of our look at what should be some of 2018’s most important clinical data , including trials for lung cancer, heart disease, melanoma, Alzheimer’s disease, rare blood disorders, and more. With part two, we’re previewing studies for migraine, brain cancer, lymphoma, peanut allergy, schizophrenia, the rare Hunter syndrome, and the flu. [ Ben Fidler, Corie Lok, and Frank Vinluan contributed to this report.]

Bio Roundup: Trials to Watch, Mega Deals, Video Game Therapy & More


With 2018 around the corner, this was a week to look ahead. At Xconomy, we zeroed in on several clinical trials that could become major stories in the life sciences. Other healthcare milestones are on the way, too. The FDA will consider for the first time whether a video game should be approved as medicine. The agency could also give its first nod for a gene therapy. We could see the first clinical trial by a U.S. company for a CRISPR-Cas9 gene editing treatment.